Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Cánceres del Hueso
National Cancer Institute®
Ultima Vez Modificado: 1 de julio del 2002
1
UI - 12013614
AU - Klungland A
TI -
[Life without DNA repair]
SO - Tidsskr Nor Laegeforen 2001 Jan 10;121(1):41-9
AD - Seksjon for molekylaerbiologi Mikrobiologisk Institutt Rikshospitalet
0027 Oslo. arne.klungland@labmed.uio.no
BACKGROUND: Faithful maintenance of the genomic information is crucial
for the survival of a species. Consequently, DNA repair processes must
have evolved early during evolution. DNA damage left unrepaired might
cause mutations leading to cell death, increased cancer incidence and
severe syndromes. MATERIAL AND METHODS: In 1968, for the first time a
link was found between a human syndrome, xeroderma pigmentosum, and a
defect in the machinery for DNA repair. These patients develop skin
cancer at an early age if not completely protected against sunlight.
More recently, several other DNA repair syndromes with cancer
predisposition and premature aging have been identified. RESULTS: A
number of DNA repair genes causing such defects have now been cloned and
characterised. These genes represent different DNA repair pathways and
some of them are involved in the coupling between DNA repair and DNA
transcription. INTERPRETATION: It is now possible to produce mice models
with defects identical to those identified in humans. During the last 5
years, more than 100 mice models with DNA repair deficiency have been
produced. Further characterisation of such mice will provide a unique
opportunity for understanding the clinical picture caused by altered DNA
repair capacity, and also elucidate the complex interaction of different
DNA repair genes.
2
UI - 11966322
AU - Nimura Y; Ismail SM; Kurimas A; Chen DJ; Stevens CW
TI -
DNA-PK and ATM are required for radiation-enhanced integration.
SO - Radiat Res 2002 May;157(5):562-7
AD - Department of Experimental Radiation Oncology, The University of Texas
M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas
77030, USA.
Ionizing radiation is known to improve transfection of exogenous DNA, a
process we have termed radiation-enhanced integration. Previous
observations have demonstrated that Ku proteins are critical for
radiation-enhanced integration. Since Ku proteins form the DNA-binding
domain of DNA-PK and since DNA-PK is important in nonhomologous DNA end
joining, it was hypothesized that DNA-PK function might be important for
radiation-enhanced integration. The ATM protein has been shown to be
important in the recognition of a variety of types of DNA damage and to
associate with DNA-PK under certain conditions. It was thus hypothesized
that ATM might also play a role in radiation-enhanced integration. To
test these hypotheses, radiation-enhanced integration was measured in
hamster cells that are defective in the catalytic subunit of DNA-PK and
in human cells containing mutant ATM. Radiation-enhanced integration was
not detected in any of the cell lines with mutant PRKDC (also known as
DNA-PKcs), but it was present in cells of the same lineage with
wild-type PRKDC. Radiation-enhanced integration was defective in cells
lacking kinase activation. ATM-deficient cell lines also showed
defective radiation-enhanced integration. These data demonstrate that
DNA-PK and ATM must both be active for radiation-enhanced integration to
be observed.
3
UI - 12072877
AU - Sun X; Becker-Catania SG; Chun HH; Hwang MJ; Huo Y; Wang Z; Mitui M;
TI -
Sanal O; Chessa L; Crandall B; Gatti RA
Early diagnosis of ataxia-telangiectasia using radiosensitivity testing.
SO - J Pediatr 2002 Jun;140(6):724-31
AD - Department of Pathology, UCLA School of Medicine, Los Angeles,
California 90095-1732, USA.
OBJECTIVES: To utilize radiosensitivity testing to improve early
diagnosis of patients with ataxia-telangiectasia (A-T). STUDY DESIGN: We
established normal ranges for the colony survival assay (CSA) by testing
cells from 104 patients with typical A-T, 29 phenotypic normal patients,
and 19 A-T heterozygotes. We also analyzed 61 samples from patients
suspected of having A-T and 25 patients with related disorders to
compare the CSA with other criteria in the diagnosis of A-T. RESULTS:
When cells were irradiated with 1.0 Gy, the mean survival fraction
(microSF +/- 1 SD) for patients with A-T was 13.1% +/- 7.2% compared
with 50.1% +/- 13.5% for healthy control patients. These data served to
define a diagnostic range for the CSA (ie, <21%), a normal range (>36%),
and a nondiagnostic intermediate range of 21% to 36%. The mutations of
patients with A-T with intermediate radiosensitivity tended to cluster
around the functional domains of the ATM gene. CONCLUSIONS: The CSA is a
useful adjunctive test for confirming an early clinical diagnosis of
A-T. However, CSA is also abnormal in other chromosomal instability and
immunodeficiency disorders.
4
UI - 12086603
AU - Taniguchi T; Garcia-Higuera I; Xu B; Andreassen PR; Gregory RC; Kim ST;
TI -
Lane WS; Kastan MB; D'Andrea AD
Convergence of the fanconi anemia and ataxia telangiectasia signaling
pathways.
SO - Cell 2002 May 17;109(4):459-72
AD - Department of Pediatric Oncology, Dana-Farber Cancer Institute and
Department of Pediatrics, Children's Hospital, Harvard Medical School,
Boston, MA 02115, USA.
Fanconi anemia (FA) and ataxia telangiectasia (AT) are clinically
distinct autosomal recessive disorders characterized by spontaneous
chromosome breakage and hematological cancers. FA cells are
hypersensitive to mitomycin C (MMC), while AT cells are hypersensitive
to ionizing radiation (IR). Here, we identify the Fanconi anemia
protein, FANCD2, as a link between the FA and ATM damage response
pathways. ATM phosphorylates FANCD2 on serine 222 in vitro. This site is
also phosphorylated in vivo in an ATM-dependent manner following IR.
Phosphorylation of FANCD2 is required for activation of an S phase
checkpoint. The ATM-dependent phosphorylation of FANCD2 on S222 and the
FA pathway-dependent monoubiquitination of FANCD2 on K561 are
independent posttranslational modifications regulating discrete cellular
signaling pathways. Biallelic disruption of FANCD2 results in both MMC
and IR hypersensitivity.
5
UI - 11859564
AU - Shiloh Y
TI -
ATM: from phenotype to functional genomics--and back.
SO - Ernst Schering Res Found Workshop 2002;(36):51-70
6
UI - 12082606
AU - Girard PM; Riballo E; Begg AC; Waugh A; Jeggo PA
TI -
Nbs1 promotes ATM dependent phosphorylation events including those
required for G1/S arrest.
SO - Oncogene 2002 Jun 20;21(27):4191-9
AD - MRC Cell Mutation Unit, University of Sussex, Brighton, East Sussex, BN1
9RR, UK.
Cell lines from Nijmegen Breakage Syndrome (NBS) and ataxia
telangiectasia (A-T) patients show defective S phase checkpoint arrest.
In contrast, only A-T but not NBS cells are significantly defective in
radiation-induced G1/S arrest. Phosphorylation of some ATM substrates
has been shown to occur in NBS cells. It has, therefore, been concluded
that Nbs1 checkpoint function is S phase specific. Here, we have
compared NBS with A-T cell lines (AT-5762ins137) that express a low
level of normal ATM protein to evaluate the impact of residual Nbs1
function in NBS cells. The radiation-induced cell cycle response of
these NBS and 'leaky' A-T cells is almost identical; normal G2/M arrest
after 2 Gy, intermediate G1/S arrest depending on the dose and an
A-T-like S phase checkpoint defect. Thus, the checkpoint assays differ
in their sensitivity to low ATM activity. Radiation-induced
phosphorylation of the ATM-dependent substrates Chk2, RPAp34 and
p53-Ser15 are similarly impaired in AT-5762ins137 and NBS cells in a
dose dependent manner. In contrast, NBS cells show normal ability to
activate ATM kinase following irradiation in vitro and in vivo. We
propose that Nbs1 facilitates ATM-dependent phosphorylation of multiple
downstream substrates, including those required for G1/S arrest.
7
UI - 9620777
AU - Matsuura S; Tauchi H; Nakamura A; Kondo N; Sakamoto S; Endo S; Smeets D;
TI -
Solder B; Belohradsky BH; Der Kaloustian VM; Oshimura M; Isomura M;
Nakamura Y; Komatsu K
Positional cloning of the gene for Nijmegen breakage syndrome.
SO - Nat Genet 1998 Jun;19(2):179-81
AD - Department of Radiation Biology, Research Institute for Radiation
Biology and Medicine, Hiroshima University, Japan.
Nijmegen breakage syndrome (NBS), also known as ataxia-telangiectasia
(AT) variant, is an autosomal recessive disorder characterized by
microcephaly, growth retardation, severe combined immunodeficiency and a
high incidence of lymphoid cancers. Cells from NBS patients display
chromosome instability, hypersensitivity to ionizing radiation and
abnormal cell-cycle regulation after irradiation, all of which are
characteristics shared with AT. Recently, the NBS locus was mapped at
8q21 by two independent approaches, complementation studies and linkage
analysis. Here, we report the positional cloning of the NBS gene, NBS1,
from an 800-kb candidate region. The gene comprises 50 kb and encodes a
protein of 754 amino acids. The amino-terminal region of the protein
shows weak homology to the yeast XRS2, MEK1, CDS1 and SPK1 proteins. The
gene is expressed at high levels in the testes, suggesting that it might
be involved in meiotic recombination. We detected the same 5-bp deletion
in 13 individuals, and conclude that it is likely to be a founder
mutation.
8
UI - 9817056
AU - Bay JO
TI -
[ATM and nibrin, partner proteins, associated with or independent of DNA
repair?]
SO - Bull Cancer 1998 Sep;85(9):743-4
9
UI - 10203748
AU - Hall J; Angele S
TI -
Radiation, DNA damage and cancer.
SO - Mol Med Today 1999 Apr;5(4):157-64
AD - Unit of Mechanisms of Carcinogenesis, International Agency for Research
on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.
hall@iarc.fr
The characterization of the rare, radiation-sensitive and cancer-prone
syndromes, ataxia telangiectasia and Nijmegen breakage syndrome, has
demonstrated that genetic predisposition increases the risk of
developing cancer after exposure to ionizing radiation (IR). Molecular
analyses of these disorders provide valuable insights into the normal
function of these two gene products in the cellular response to
IR-induced DNA damage. Their contribution to a cellular radiosensitive
phenotype and their role in sporadic cancers can now be fully assessed.
For example, the gene ataxia telangiectasia mutated (ATM) has recently
been shown to be a tumour suppressor gene in T-cell prolymphocytic
leukaemia, and there is increasing evidence that individuals with one
mutated ATM or Nijmegen breakage syndrome (NBS1) allele have an
increased predisposition to cancer.
10
UI - 10528155
AU - Halazonetis TD; Shiloh Y
TI -
Many faces of ATM: eighth international workshop on
ataxia-telangiectasia.
SO - Biochim Biophys Acta 1999 Oct 29;1424(2-3):R45-55
AD - Wistar Institute, Department of Pathology of the University of
Pennsylvania, Philadelphia, PA, USA. halazonetis@wistar.upenn.edu
11
UI - 10610129
AU - Soussi T
TI -
[Genes and cancer. NBS1 (Nijmegen breakage syndrome). Repair gene]
SO - Bull Cancer 1999 Oct;86(10):803-4
AD - Institut Curie, Paris.
12
UI - 10612394
AU - Stewart GS; Maser RS; Stankovic T; Bressan DA; Kaplan MI; Jaspers NG;
TI -
Raams A; Byrd PJ; Petrini JH; Taylor AM
The DNA double-strand break repair gene hMRE11 is mutated in individuals
with an ataxia-telangiectasia-like disorder.
SO - Cell 1999 Dec 10;99(6):577-87
AD - The University of Birmingham CRC Institute for Cancer Studies, The
Medical School Edgbaston, United Kingdom.
We show that hypomorphic mutations in hMRE11, but not in ATM, are
present in certain individuals with an ataxia-telangiectasia-like
disorder (ATLD). The cellular features resulting from these hMRE11
mutations are similar to those seen in A-T as well as NBS and include
hypersensitivity to ionizing radiation, radioresistant DNA synthesis,
and abrogation of ATM-dependent events, such as the activation of Jun
kinase following exposure to gamma irradiation. Although the mutant
hMre11 proteins retain some ability to interact with hRad50 and Nbs1,
formation of ionizing radiation-induced hMre11 and Nbs1 foci was absent
in hMRE11 mutant cells. These data demonstrate that ATM and the
hMre11/hRad50/Nbs1 protein complex act in the same DNA damage response
pathway and link hMre11 to the complex pathology of A-T.
13
UI - 10802669
AU - Gatei M; Young D; Cerosaletti KM; Desai-Mehta A; Spring K; Kozlov S;
TI -
Lavin MF; Gatti RA; Concannon P; Khanna K
ATM-dependent phosphorylation of nibrin in response to radiation
exposure.
SO - Nat Genet 2000 May;25(1):115-9
AD - The Queensland Institute of Medical Research, PO Royal Brisbane
Hospital, Brisbane, Queensland, Australia.
Mutations in the gene ATM are responsible for the genetic disorder
ataxia-telangiectasia (A-T), which is characterized by cerebellar
dysfunction, radiosensitivity, chromosomal instability and cancer
predisposition. Both the A-T phenotype and the similarity of the ATM
protein to other DNA-damage sensors suggests a role for ATM in
biochemical pathways involved in the recognition, signalling and repair
of DNA double-strand breaks (DSBs). There are strong parallels between
the pattern of radiosensitivity, chromosomal instability and cancer
predisposition in A-T patients and that in patients with Nijmegen
breakage syndrome (NBS). The protein defective in NBS, nibrin (encoded
by NBS1), forms a complex with MRE11 and RAD50 (refs 1,2). This complex
localizes to DSBs within 30 minutes after cellular exposure to ionizing
radiation (IR) and is observed in brightly staining nuclear foci after a
longer period of time. The overlap between clinical and cellular
phenotypes in A-T and NBS suggests that ATM and nibrin may function in
the same biochemical pathway. Here we demonstrate that nibrin is
phosphorylated within one hour of treatment of cells with IR. This
response is abrogated in A-T cells that either do not express ATM
protein or express near full-length mutant protein. We also show that
ATM physically interacts with and phosphorylates nibrin on serine 343
both in vivo and in vitro. Phosphorylation of this site appears to be
functionally important because mutated nibrin (S343A) does not
completely complement radiosensitivity in NBS cells. ATM phosphorylation
of nibrin does not affect nibrin-MRE11-RAD50 association as revealed by
radiation-induced foci formation. Our data provide a biochemical
explanation for the similarity in phenotype between A-T and NBS.
14
UI - 10839519
AU - Wang JY
TI -
Cancer. New link in a web of human genes.
SO - Nature 2000 May 25;405(6785):404-5
15
UI - 10839544
AU - Zhao S; Weng YC; Yuan SS; Lin YT; Hsu HC; Lin SC; Gerbino E; Song MH;
TI -
Zdzienicka MZ; Gatti RA; Shay JW; Ziv Y; Shiloh Y; Lee EY
Functional link between ataxia-telangiectasia and Nijmegen breakage
syndrome gene products.
SO - Nature 2000 May 25;405(6785):473-7
AD - Department of Molecular Medicine/Institute of Biotechnology, The
University of Texas Health Science Center at San Antonio, 78245-3207,
USA.
Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are
recessive genetic disorders with susceptibility to cancer and similar
cellular phenotypes. The protein product of the gene responsible for
A-T, designated ATM, is a member of a family of kinases characterized by
a carboxy-terminal phosphatidylinositol 3-kinase-like domain. The NBS1
protein is specifically mutated in patients with Nijmegen breakage
syndrome and forms a complex with the DNA repair proteins Rad50 and
Mrel1. Here we show that phosphorylation of NBS1, induced by ionizing
radiation, requires catalytically active ATM. Complexes containing ATM
and NBS1 exist in vivo in both untreated cells and cells treated with
ionizing radiation. We have identified two residues of NBS1, Ser 278 and
Ser 343 that are phosphorylated in vitro by ATM and whose modification
in vivo is essential for the cellular response to DNA damage. This
response includes S-phase checkpoint activation, formation of the
NBS1/Mrel1/Rad50 nuclear foci and rescue of hypersensitivity to ionizing
radiation. Together, these results demonstrate a biochemical link
between cell-cycle checkpoints activated by DNA damage and DNA repair in
two genetic diseases with overlapping phenotypes.
16
UI - 10839545
AU - Wu X; Ranganathan V; Weisman DS; Heine WF; Ciccone DN; O'Neill TB; Crick
TI -
KE; Pierce KA; Lane WS; Rathbun G; Livingston DM; Weaver DT
ATM phosphorylation of Nijmegen breakage syndrome protein is required in
a DNA damage response.
SO - Nature 2000 May 25;405(6785):477-82
AD - Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Nijmegen breakage syndrome (NBS) is characterized by extreme radiation
sensitivity, chromosomal instability and cancer. The phenotypes are
similar to those of ataxia telangiectasia mutated (ATM) disease, where
there is a deficiency in a protein kinase that is activated by DNA
damage, indicating that the Nbs and Atm proteins may participate in
common pathways. Here we report that Nbs is specifically phosphorylated
in response to gamma-radiation, ultraviolet light and exposure to
hydroxyurea. Phosphorylation of Nbs mediated by gamma-radiation, but not
that induced by hydroxyurea or ultraviolet light, was markedly reduced
in ATM cells. In vivo, Nbs was phosphorylated on many serine residues,
of which S343, S397 and S615 were phosphorylated by Atm in vitro. At
least two of these sites were underphosphorylated in ATM cells.
Inactivation of these serines by mutation partially abrogated
Atm-dependent phosphorylation. Reconstituting NBS cells with a mutant
form of Nbs that cannot be phosphorylated at selected, ATM-dependent
serine residues led to a specific reduction in clonogenic survival after
gamma-radiation. Thus, phosphorylation of Nbs by Atm is critical for
certain responses of human cells to DNA damage.
17
UI - 10854333
AU - Eggleston A
TI -
Convergence of DNA repair and cell-cycle checkpoint control.
SO - Nat Cell Biol 2000 Jun;2(6):E95
18
UI - 10838806
AU - Tauchi H
TI -
Positional cloning and functional analysis of the gene responsible for
Nijmegen breakage syndrome, NBS1.
SO - J Radiat Res (Tokyo) 2000 Mar;41(1):9-17
AD - Department of Radiation Biology, Hiroshima University, Japan.
htauchi@hiroshima-u.ac.jp
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive disorder
characterized by microcephaly, combined immunodeficiency, and a high
incidence of lymphoid tumor. Cells from NBS patients show chromosomal
instability, hypersensitivity to ionizing radiation and abnormal
p53-mediated cell cycle regulation. We cloned the underlying gene for
NBS, designated NBS1, by complementation-assisted positional cloning
from the candidate region 8q21. Large genomic sequencing, as well as a
search using computer programs, provides a powerful approach for
identifying the underlying gene for a disease. The NBS1 gene encodes a
protein of 754 amino acids that has FHA and BRCT domains which often are
conserved in cell-cycle checkpoint proteins. The gene has weak homology
to the yeast (Saccharomyces cerevisiae) Xrs2 protein in the N-terminus
region. Like yeast Xrs2, the NBS1 protein forms a complex with
hRAD50/hMRE11, and the complex is condensed as foci in the nucleus after
irradiation, indicative that this triple-complex is a crucial factor in
DNA repair. Functional analysis of the NBS1 protein is in progress and
it should provide further clues to understanding the repair mechanism of
radiation-induced DNA double-strand breaks.
19
UI - 10852373
AU - Kleier S; Herrmann M; Wittwer B; Varon R; Reis A; Horst J
TI -
Clinical presentation and mutation identification in the NBS1 gene in a
boy with Nijmegen breakage syndrome.
SO - Clin Genet 2000 May;57(5):384-7
AD - Institut fur Humangenetik, Westfalische-Wilhelms-Universitat, Munster,
Germany.
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive disorder
which belongs to the group of inherited chromosomal instability
syndromes. The clinical characteristics include severe microcephaly, a
dysmorphic facies, and immunodeficiency with predisposition to
malignancies. While the cellular characteristics of ataxia
teleangiectasia (AT) and NBS are similar, the clinical findings are
quite distinct. NBS patients show characteristic microcephaly, which is
rare in association with AT and they do not develop ataxia and
teleangiectasia. Recently, the gene mutated in NBS has been identified.
Here we report a 5-year-old Bosnian boy with severe microcephaly.
Because of multiple structural aberrations involving chromosomes 7 and
14 typical for AT (MIM 208900) and NBS (MIM 251260), AT was diagnosed.
We suggested the diagnosis of NBS because of the boy's remarkable
microcephaly, his facial appearance, and the absence of ataxia and
teleangiectasia. DNA analysis was performed and revealed that the boy is
homozygous for the major mutation (657de15) in the NBS1 gene. This
finding confirms the diagnosis of NBS in our patient and offers the
possibility to perform a most reliable prenatal diagnosis in a further
pregnancy.
20
UI - 11022012
AU - Nemeth AH; Bochukova E; Dunne E; Huson SM; Elston J; Hannan MA; Jackson
TI -
M; Chapman CJ; Taylor AM
Autosomal recessive cerebellar ataxia with oculomotor apraxia
(ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34.
SO - Am J Hum Genet 2000 Nov;67(5):1320-6
AD - Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, United
Kingdom. andrea.nemeth@well.ox.ac.uk
Ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome
[AOA]; MIM 208920) is an autosomal recessive disorder characterized by
ataxia, oculomotor apraxia, and choreoathetosis. These neurological
features resemble those of ataxia-telangiectasia (AT), but in AOA there
are none of the extraneurological features of AT, such as
immunodeficiency, neoplasia, chromosomal instability, or sensitivity to
ionizing radiation. It is unclear whether these patients have a true
disorder of chromosomal instability or a primary neurodegenerative
syndrome, and it has not been possible to identify the defective gene in
AOA, since the families have been too small for linkage analysis. We
have identified a new family with AOA, and we show that the patients
have no evidence of chromosomal instability or sensitivity to ionizing
radiation, suggesting that AOA in this family is a true primary
cerebellar ataxia. We have localized the disease gene, by linkage
analysis and homozygosity mapping, to a 15.9-cM interval on chromosome
9q34. This work will ultimately allow the disease gene to be identified
and its relevance to other types of autosomal recessive cerebellar
ataxias to be determined.
21
UI - 11137027
AU - Rhind N; Russell P
TI -
Checkpoints: it takes more than time to heal some wounds.
SO - Curr Biol 2000 Dec 14-28;10(24):R908-11
AD - The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla,
California 92037, USA. rhind@scripps.edu
The S-phase DNA damage checkpoint seems to provide a twist on the
checkpoint theme. Instead of delaying replication and allowing repair as
a consequence, it may activate repair and delay replication as a
consequence.
22
UI - 11288710
AU - Maraschio P; Danesino C; Antoccia A; Ricordy R; Tanzarella C; Varon R;
TI -
Reis A; Besana D; Guala A; Tiepolo L
A novel mutation and novel features in Nijmegen breakage syndrome.
SO - J Med Genet 2001 Feb;38(2):113-7
23
UI - 11267829
AU - Kraakman-van der Zwet M; Overkamp WJ; Jaspers NG; Natarajan AT; Lohman
TI -
PH; Zdzienicka MZ
Complementation of chromosomal aberrations in AT/NBS hybrids: inadequacy
of RDS as an endpoint in complementation studies with immortal NBS
cells.
SO - Mutat Res 2001 Apr 4;485(3):177-85
AD - Department of Radiation Genetics and Chemical Mutagenesis - MGC,
Wassenaarseweg 72, 2333 AL, Leiden University Medical Center, Leiden,
The Netherlands.
Nijmegen breakage syndrome (NBS) and ataxia telangiectasia (AT) are rare
autosomal recessive hereditary disorders characterized by
radiosensitivity, chromosomal instability, immunodeficiency and
proneness to cancer. Although the clinical features of both syndromes
are quite distinct, the cellular characteristics are very similar. Cells
from both NBS and AT patients are hypersensitive to ionizing radiation
(IR), show elevated levels of chromosomal aberrations and display
radioresistant DNA synthesis (RDS). The proteins defective in NBS and
AT, NBS1 and ATM, respectively, are involved in the same pathway, but
their exact relationship is not yet fully understood. Stumm et al. (Am.
J. Hum. Genet. 60 (1997) 1246) have reported that hybrids of AT and NBS
lymphoblasts were not complemented for chromosomal aberrations. In
contrast, we found that X-ray-induced cell killing as well as
chromosomal aberrations were complemented in proliferating
NBS-1LBI/AT5BIVA hybrids, comparable to that in NBS-1LBI cells after
transfer of a single human chromosome 8 providing the NBS1 gene. RDS
observed in AT5BIVA cells was reduced in these hybrids to the level of
that seen in immortal NBS-1LBI cells. However, the level of DNA
synthesis, following ionizing radiation, in SV40 transformed wild-type
cell lines was the same as in NBS-1LBI cells. Only primary wild-type
cells showed stronger inhibition of DNA synthesis. In summary, these
results clearly indicate that RDS cannot be used as an endpoint in
functional complementation studies with immortal NBS-1LBI cells, whereas
the cytogenetic assay is suitable for complementation studies with
immortal AT and NBS cells.
24
UI - 11282395
AU - Harfst E; Cooper S; Neubauer S; Distel L; Grawunder U
TI -
Normal V(D)J recombination in cells from patients with Nijmegen breakage
syndrome.
SO - Mol Immunol 2000 Oct;37(15):915-29
AD - Basel Institute for Immunology, Grenzacherstr. 487, CH-4005, Basel,
Switzerland.
The majority of antigen receptor diversity in mammals is generated by
V(D)J recombination. During this process DNA double strand breaks are
introduced at recombination signals by lymphoid specific RAG1/2 proteins
generating blunt ended signal ends and hairpinned coding ends. Rejoining
of all DNA ends requires ubiquitously expressed DNA repair proteins,
such as Ku70/86 and DNA ligase IV/XRCC4. In addition, the formation of
coding joints depends on the function of the scid gene encoding the
catalytic subunit of DNA-dependent protein kinase, DNA-PK(CS), that is
somehow required for processing of coding end hairpins. Recently, it was
shown that purified RAG1/2 proteins can cleave DNA hairpins in vitro,
but the same activity was also described for a protein complex of the
DNA repair proteins Nbs1/Mre11/Rad50. This leaves the possibility that
either protein complex might be involved in coding end processing in
V(D)J recombination. We have therefore analyzed V(D)J recombination in
cells from patients with Nijmegen breakage syndrome, carrying a mutation
in the nbs1 gene. We find that V(D)J recombination frequencies and the
quality of signal and coding joining are comparable to wild-type
controls, as analyzed by a cellular V(D)J recombination assay. In
addition, we did not detect significant differences in CDR3 sequences of
endogenous Ig lambdaL and kappaL chain gene loci cloned from peripheral
blood lymphocytes of an NBS patient and of healthy individuals. These
findings suggest that the Nbs1/Mre11/Rad50 complex is not involved in
coding end processing of V(D)J recombination.
25
UI - 11809797
AU - Xu B; Kim ST; Lim DS; Kastan MB
TI -
Two molecularly distinct G(2)/M checkpoints are induced by ionizing
irradiation.
SO - Mol Cell Biol 2002 Feb;22(4):1049-59
AD - Department of Hematology-Oncology, St. Jude Children's Research
Hospital, Memphis, Tennessee 38105, USA.
Cell cycle checkpoints are among the multiple mechanisms that eukaryotic
cells possess to maintain genomic integrity and minimize tumorigenesis.
Ionizing irradiation (IR) induces measurable arrests in the G(1), S, and
G(2) phases of the mammalian cell cycle, and the ATM (ataxia
telangiectasia mutated) protein plays a role in initiating checkpoint
pathways in all three of these cell cycle phases. However, cells lacking
ATM function exhibit both a defective G(2) checkpoint and a prolonged
G(2) arrest after IR, suggesting the existence of different types of
G(2) arrest. Two molecularly distinct G(2)/M checkpoints were
identified, and the critical importance of the choice of G(2)/M
checkpoint assay was demonstrated. The first of these G(2)/M checkpoints
occurs early after IR, is very transient, is ATM dependent and dose
independent (between 1 and 10 Gy), and represents the failure of cells
which had been in G(2) at the time of irradiation to progress into
mitosis. Cell cycle assays that can distinguish mitotic cells from G(2)
cells must be used to assess this arrest. In contrast, G(2)/M
accumulation, typically assessed by propidium iodide staining, begins to
be measurable only several hours after IR, is ATM independent, is dose
dependent, and represents the accumulation of cells that had been in
earlier phases of the cell cycle at the time of exposure to radiation.
G(2)/M accumulation after IR is not affected by the early G(2)/M
checkpoint and is enhanced in cells lacking the IR-induced S-phase
checkpoint, such as those lacking Nbs1 or Brca1 function, because of a
prolonged G(2) arrest of cells that had been in S phase at the time of
irradiation. Finally, neither the S-phase checkpoint nor the G(2)
checkpoints appear to affect survival following irradiation. Thus, two
different G(2) arrest mechanisms are present in mammalian cells, and the
type of cell cycle checkpoint assay to be used in experimental
investigation must be thoughtfully selected.
26
UI - 11889050
AU - Kang J; Bronson RT; Xu Y
TI -
Targeted disruption of NBS1 reveals its roles in mouse development and
DNA repair.
SO - EMBO J 2002 Mar 15;21(6):1447-55
AD - Section of Molecular Biology, Division of Biology, University of
California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0322, USA.
Nijmegen breakage syndrome (NBS) is an autosomal recessive hereditary
disease that shares some common defects with ataxia-telangiectasia. The
gene product mutated in NBS, named NBS1, is a component of the Mre11
complex that is involved in DNA strand-break repair. To elucidate the
physiological roles of NBS1, we disrupted the N-terminal exons of the
NBS1 gene in mice. NBS1(m/m) mice are viable, growth retarded and
hypersensitive to ionizing radiation (IR). NBS1(m/m) mice exhibit
multiple lymphoid developmental defects, and rapidly develop thymic
lymphoma. In addition, female NBS1(m/m) mice are sterile due to
oogenesis failure. NBS1(m/m) cells are impaired in cellular responses to
IR and defective in cellular proliferation. Most systematic and cellular
defects identified in NBS1(m/m) mice recapitulate those in NBS patients,
and are essentially identical to those observed in Atm(-/-) mice. In
contrast to Atm(-/-) mice, spermatogenesis is normal in NBS1(m/m) mice,
indicating that distinct roles of ATM have differential requirement for
NBS1 activity. Thus, NBS1 and ATM have overlapping and distinct
functions in animal development and DNA repair.
27
UI - 11981817
AU - Pan Q; Petit-Frere C; Lahdesmaki A; Gregorek H; Chrzanowska KH;
TI -
Hammarstrom L
Alternative end joining during switch recombination in patients with
ataxia-telangiectasia.
SO - Eur J Immunol 2002 May;32(5):1300-8
AD - Division of Clinical Immunology, IMPI, Karolinska Institutet at Huddinge
Hospital, and Center for Biotechnology and Center for Oral Biology,
NOVUM, Huddinge, Sweden.
Ataxia-Telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are
recessive genetic diseases with similar cellular phenotypes that are
caused by mutations in the recently described ATM (encoding ATM) and
NBS1 (encoding p95) genes, respectively. Both disorders are accompanied
by immunodeficiency in a majority of patients, but the mechanism
involved has as yet not been established. We demonstrate that in cells
from A-T patients, the switch (S) recombination junctions are aberrant
and characterized by a strong dependence on short sequence homologies
and devoid of normally occurring mutations around the breakpoint. A low
number of S fragments were generated in cells from NBS patients and
showed only limited dependence on sequence identity and mutation
frequencies were similar to those observed in normal controls. We
propose that ATM and p95 are both involved in the final step(s) in class
switch recombination with related, but disparate, functional roles.
Thus, the general pathway involved in DNA repair also has a major
influence on the immunoglobulin isotype switching process.
28
UI - 12072552
AU - Lei H; Pospisilova D; Lindblom A; Vorechovsky I
TI -
Re: Dominant negative ATM mutations in breast cancer families.
SO - J Natl Cancer Inst 2002 Jun 19;94(12):951-2; discussion 952
29
UI - 11820740
AU - Cao JP; Meyn MS; Eckardt-Schupp F; Fritz E
TI -
TEL1 from Saccharomyces cerevisiae suppresses chromosome aberrations
induced by ionizing radiation in ataxia-telangiectasia cells without
affecting cell cycle checkpoints.
SO - Radiat Environ Biophys 2001 Dec;40(4):309-15
AD - Soochow University, Suzhou, PR China.
The TEL1 gene from Saccharomyces cerevisiae has been shown to be the
closest sequence homologue to ATM, the gene mutated in
ataxia-telangiectasia (A-T) patients. Functional homology shared between
the ATM and Tell proteins has recently been demonstrated based on
heterologous expression of the TEL1 gene in human cells derived from A-T
patients. TEL1 expression complemented specific cellular A-T
deficiencies, i.e. increased radiation-induced apoptosis, telomere
shortening and spontaneous hyperrecombination. The mechanism of cellular
A-T complementation by TEL1 appears to be independent of p53-dependent
signaling cascades, since the deficiency of A-T cells to properly induce
p53 upon ionizing radiation was not corrected by TEL1. We now find that
the basic number of chromosome aberrations is increased and the number
of radiation-induced chromosome aberrations is suppressed in A-T cells
upon TEL1 expression. In cell cycle analyses, we find no changes in
basic cell cycle distribution or in radiation-induced cell cycle
checkpoints following TEL1 expression. We conclude that the
radioprotective function of the Tel1 protein includes suppression of
apoptosis and suppression of chromosome aberrations, and that both
cellular end-points can be uncoupled from ionizing radiation-induced
cell cycle checkpoints.
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.
Dr. Mao talks about complementary and alternative medicine and the importance of being open about their use with cancer caregivers. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

